Follow
Antonio Piras
Antonio Piras
Associate Director, AstraZeneca
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13096*2021
Age related macular degeneration and drusen: neuroinflammation in the retina
E Buschini, A Piras, R Nuzzi, A Vercelli
Progress in neurobiology 95 (1), 14-25, 2011
2842011
Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive …
A Piras, L Collin, F Grüninger, C Graff, A Rönnbäck
Acta neuropathologica communications 4, 1-13, 2016
2182016
Activation of autophagy in a rat model of retinal ischemia following high intraocular pressure
A Piras, D Gianetto, D Conte, A Bosone, A Vercelli
PloS one 6 (7), e22514, 2011
1272011
Aβ1-42 monomers or oligomers have different effects on autophagy and apoptosis
M Guglielmotto, D Monteleone, A Piras, V Valsecchi, M Tropiano, ...
Autophagy 10 (10), 1827-1843, 2014
902014
Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis
M Boido, A Piras, V Valsecchi, G Spigolon, K Mareschi, I Ferrero, A Vizzini, ...
Cytotherapy 16 (8), 1059-1072, 2014
902014
Expression of muscle-specific MiRNA 206 in the progression of disease in a murine SMA model
V Valsecchi, M Boido, E De Amicis, A Piras, A Vercelli
PloS one 10 (6), e0128560, 2015
702015
Aβ1‐42‐mediated down‐regulation of Uch‐L1 is dependent on NF‐κB activation and impaired BACE1 lysosomal degradation
M Guglielmotto, D Monteleone, M Boido, A Piras, L Giliberto, R Borghi, ...
Aging cell 11 (5), 834-844, 2012
662012
Selective vulnerability of spinal and cortical motor neuron subpopulations in delta7 SMA mice
P d’Errico, M Boido, A Piras, V Valsecchi, E De Amicis, D Locatelli, ...
PloS one 8 (12), e82654, 2013
602013
Targeting Alzheimer's disease with gene and cell therapies
R Loera‐Valencia, A Piras, MAM Ismail, S Manchanda, H Eyjolfsdottir, ...
Journal of Internal Medicine 284 (1), 2-36, 2018
582018
Inhibition of autophagy delays motoneuron degeneration and extends lifespan in a mouse model of spinal muscular atrophy
A Piras, L Schiaffino, M Boido, V Valsecchi, M Guglielmotto, E De Amicis, ...
Cell death & disease 8 (12), 3223, 2017
522017
Amyloid Β-peptide increases mitochondria-endoplasmic reticulum contact altering mitochondrial function and autophagosome formation in Alzheimer’s disease-related models
NS Leal, G Dentoni, B Schreiner, L Naia, A Piras, C Graff, A Cattaneo, ...
Cells 9 (12), 2552, 2020
432020
Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells
ES Hanemaaijer, M Panahi, N Swaddiwudhipong, S Tikka, B Winblad, ...
European Journal of Cell Biology 97 (8), 557-567, 2018
272018
Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis
A Radwanska, CT Cottage, A Piras, C Overed-Sayer, C Sihlbom, ...
JCI insight 7 (16), 2022
182022
Characterization of selective and potent JAK1 inhibitors intended for the inhaled treatment of asthma
M Nilsson, M Rhedin, R Hendrickx, S Berglund, A Piras, P Blomgran, ...
Drug design, development and therapy, 2901-2917, 2023
112023
Autophagy inhibition: a new therapeutic target in spinal muscular atrophy
A Piras, M Boido
Neural Regeneration Research 13 (5), 813-814, 2018
102018
Advantages and pitfalls in experimental models of ALS
M Boido, E Buschini, A Piras, G Spigolon, V Valsecchi, L Mazzini, ...
Amyotrophic lateral sclerosis, 125-140, 2012
62012
Motor and molecular analysis to detect the early symptoms in a mouse amyotrophic lateral sclerosis model
V Valsecchi, M Boido, A Piras, G Spigolon, A Vercelli
Health 2013, 2013
42013
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ...
Guidelines for the use and interpretation of assays for monitoring autophagy …, 2012
42012
Intratracheal administration of a PROTAC with subnanomolar potency induces BRD4 degradation in the lung without systemic target engagement
U Hedström, A Piras, R Pehrson, J Liu, A Wilson, K Carlsson, K Ribbing, ...
European Respiratory Journal 62 (suppl 67), 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20